Harrow Health (HROW) Tops Q4 EPS by 19c

Harrow Health (NASDAQ: HROW) reported Q4 EPS of $0.07, $0.19 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $20.3 million versus the consensus estimate of $21.4 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Jefferies Downgrades Sunway Healthcare Holdings (SUNMED:MK) to Hold
• Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance